Xiaolei Li
Impact in
- Rehabilitation top 10%
- Exercise and Physiological Responses
-
- Muscle metabolism and nutrition
- Plant Pathogens and Fungal Diseases
Papers in
-
- Ubiquitin and proteasome pathways 2
- Glycosylation and Glycoproteins Research 2
- Natural product bioactivities and synthesis 2
- DNA Repair Mechanisms 1
- Oncology 5
- Peptidase Inhibition and Analysis 2
- Co-authors
- N H Chua (1 shared paper)Gregory Jedd (1 shared paper)Naweed I. Naqvi (1 shared paper)Rong Lu (4 shared papers)Zhi Yao (4 shared papers)Rui Ma (3 shared papers)Huali Zhang (3 shared papers)Yanjiao Zhou (1 shared paper)
- Journals
- International Journal of COPD (1 paper)Molecular Biology Reports (1 paper)Medicine (1 paper)Journal of Thrombosis and Thrombolysis (1 paper)Genes & Diseases (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Xiaolei Li
22 papers receiving 491 citations
Peers
Comparison fields: 5 of 79
- Rehabilitation 48
- Cell Biology 75
- Molecular Biology 254
- Pharmacology 55
- Complementary and alternative medicine 26
Countries citing papers authored by Xiaolei Li
This map shows the geographic impact of Xiaolei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolei Li more than expected).
Fields of papers citing papers by Xiaolei Li
This network shows the impact of papers produced by Xiaolei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolei Li. The network helps show where Xiaolei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaolei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 150 | |
| 2 | 2008 | 122 | |
| 3 | 2008 | 44 | |
| 4 | 2003 | 28 | |
| 5 | 2022 | 24 | |
| 6 | 2022 | 22 | |
| 7 | 2021 | 16 | |
| 8 | 2020 | 16 | |
| 9 | 2018 | 15 | |
| 10 | 2018 | 11 | |
| 11 | 2008 | 9 | |
| 12 | 2024 | 7 | |
| 13 | 2015 | 7 | |
| 14 | 2020 | 6 | |
| 15 | 2024 | 5 | |
| 16 | 2023 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2023 | 3 | |
| 19 | 2007 | 3 | |
| 20 | 2024 | 3 |
About Xiaolei Li
Xiaolei Li is a scholar working on Molecular Biology, Oncology, Infectious Diseases, Cancer Research and Pharmacology, having authored 23 papers that have together received 500 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (2 papers), Glycosylation and Glycoproteins Research (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Natural product bioactivities and synthesis (2 papers), Peptidase Inhibition and Analysis (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), DNA Repair Mechanisms (1 paper) and Muscle metabolism and nutrition (1 paper). The work is most often cited by research in Rehabilitation (48 citations), Cell Biology (75 citations), Molecular Biology (254 citations), Pharmacology (55 citations) and Complementary and alternative medicine (26 citations). Xiaolei Li has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include N H Chua, Gregory Jedd, Naweed I. Naqvi, Rong Lu, Zhi Yao, Rui Ma, Huali Zhang, Yanjiao Zhou, Lijuan Chen and Junqiang Lv. Their work appears in journals such as International Journal of COPD, Molecular Biology Reports, Medicine, Journal of Thrombosis and Thrombolysis and Genes & Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.